Novartis has been contributing to the realization of the MDGs since their launch in 2000. First and foremost, Novartis contributes through its core business – the discovery, development and marketing of innovative drugs, helping to save millions of lives and improve quality of life for hundreds of millions of patients...Beyond the core business, philanthropic commitments by Novartis contribute specifically to the realization of the MDGs. The Novartis Foundation for Sustainable Development (NFSD), fully funded by Novartis, is a competence center for corporate responsibility and international health, focused on the poorest of the poor.